US Market News
4月前
Global Medical REIT Inc. Announces Dates for 2025 Fourth Quarter and Year-End Earnings Release and WebcastFebruary 11, 2026 4:17 PM
Business Wire
Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”), announced today that it intends to release its fourth quarter and year-end 2025 financial results after the market closes on Wednesday, February 25, 2026. The Company intends to hold a conference call to discuss those results the following day, Thursday, February 26, 2026, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer Robert Kiernan, Chief Investment Officer Alfonzo Leon and Chief Operating Officer Danica Holley.
Please note, at the time it releases its fourth quarter and year-end 2025 financial results, the Company's previously announced name change to Chiron Real Estate Inc. will have taken effect.
Webcast Information
Participants may access the call via live webcast by visiting the “Investor Relations” section of the Company's new website at www.chironre.com/investor/investor-overview/default.aspx. The Company encourages use of the webcast due to potential extended wait times to access the conference call via dial-in.
Conference Call
For those unable to access the webcast, participants from within the U.S. should dial 1-877-704-4453, and participants from outside the U.S. should dial 1-201-389-0920.
Replay Information
A replay of the call will be available from approximately 12:00 p.m. Eastern Time on February 26, 2026, through 11:59 p.m. Eastern Time on March 12, 2026. To access the replay, the domestic dial-in number is 1-844-512-2921, the international dial-in number is 1-412-317-6671, and the passcode is 13758015. The archive of the webcast will be available on the Company's website for a limited time.
About Global Medical REIT Inc.
Global Medical REIT Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Additional information on GMRE can be obtained on its website at www.globalmedicalreit.com. Beginning on February 23, 2026, the Company’s new website will be www.chironre.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260211704691/en/
Investor Relations:
Email: Investors@globalmedicalreit.com
Phone: 202.524.6869
Original: Global Medical REIT Inc. Announces Dates for 2025 Fourth Quarter and Year-End Earnings Release and Webcast
Big Brother
12年前
David A. Young appointed as new CEO here.
http://www.linkedin.com/pub/david-young/25/164/748
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9758802
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 5 th , 2014, the Board of Directors of Global Medical REIT (the “Company”) appointed David A. Young as Chief Executive Officer to hold office until the next annual meeting of shareholders and until their successor is duly elected and qualified or until his resignation or removal.
David A. Young is a 35-year veteran of healthcare real estate. Mr. Young was the founder and CEO of Global Medical Realty Trust, which focused on sponsored development and equity lease financing of market leading healthcare real estate. As the Senior Vice Pre sident of Business Development at GE Capital between 2004 and 2008, Mr. Young organized, co-launched and grew GE Capital’s first acute medical real estate financing initiative.
Over the years, Mr. Young has built a strong track record developing several successful NYSE-listed healthcare REITs such as Windrose Medical Properties, the core assets of which he grew from start-up to over US$500 million. He also grew the portfolio of Healthcare Property Investors, Inc. from US$300 million to over US$3.5 billion, and its net earnings from US$27 million to US$91 million, delivering an internal rate of return of 23% per annum over his ten-year tenure.
In serving as CEO, Mr. Young’s role will be to manage the Company’s operations, marketing, and business development. Together with other consultants, he will develop a portfolio of medical and healthcare-related assets in the United States and selected international countries which offer recurring yields.
The board of directors appointed Mr. Young in recognition of his abilities to assist the Company in expanding its business and the contributions he can make to the Company’s strategic direction. Mr. Young has not yet been appointed to any board committees.
The Company has not entered into any compensation arrangements with Mr. Young. With the appointment of Mr. Young as CEO, Mr. Conn Flanigan is resigning as CEO. Mr. Flanigan is not resigning due to any disagreement with the Company, and will continue to serve the Company as Secretary, Acting Chief Financial Officer, and as a member of the Board of Directors.
db7
13年前
Form 8-K for SCOOP MEDIA, INC.
--------------------------------------------------------------------------------
4-Oct-2013
Changes in Control or Registrant, Change in Directors or Principal Officers
Item 5.01 Changes in Control of Registrant.
On September 30, 2013, Xpress Group, Ltd., a Hong Kong company ("Xpress") purchased 5,500,000 shares (the "Shares") of Scoop Media, Inc.'s (the "Company") common stock representing approximately 68.7% of its issued and outstanding common stock. The Shares were purchased from Yukon Industries, Inc. for $55,000.00 payable in cash at closing.
Xpress used funds from its working capital to acquire the Shares.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 30, 2013 the Company's board of directors appointed Conn Flanigan as its Chief Executive Officer, Chief Financial Officer and a director to hold office until the next annual meeting of shareholders and until his successor is duly elected and qualified or until his resignation or removal.
Mr. Flanigan has served as General Counsel with eBanker Corporate Services, Inc., a Colorado subsidiary of Xpress since 2007. From 2000 to 2007 Mr. Flanigan served as Corporate Counsel to eVision Corporate Services, Inc., a Colorado subsidiary of Xpress. Mr. Flanigan received a B.A. in International Relations from the University of San Diego in 1990 and a Juris Doctor Degree from the University of Denver Sturm College of Law in 1996.
The board of directors appointed Mr. Flanigan in recognition of the importance of his abilities to assist the Company in expanding its business and the contributions he can make to its strategic direction.
The Company has not entered into any compensation arrangements with Mr. Flanigan.
Following the appointment of Mr. Flanigan as an officer and director of the Company, Awais Khan resigned his positions as our Chief Executive Officer, Chief Financial Officer and Director effective as of October 1, 2013. Richard Lee also resigned his positions as Vice President and Director effective October 1, 2013.
Hot Features
プレミアム
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Renee
10年前
メールアドレスで登録
